India’s bioeconomy is on a remarkable growth trajectory, with Union Minister of Science and Technology, Dr. Jitendra Singh, revealing that from a modest $10 billion in 2014, it surged to $165.7 billion in 2024. Looking ahead, the ambitious target is set at $300 billion by 2030, showcasing the nation’s commitment to leveraging biotechnology for economic, environmental, and employment benefits.
In a significant move towards this goal, the minister unveiled the Biotechnology for Economy, Environment, and Employment (BioE3) Challenge for Youth and inaugurated India’s first National Biofoundry Network. These initiatives are designed to position biotechnology as a key driver of India’s overall growth, emphasizing the pivotal role it can play in shaping the country’s future.
Under the comprehensive BioE3 Policy, India’s biotechnology sector has witnessed rapid advancements and pivotal milestones, solidifying its stance as a key player in the global biotech landscape. The Department of Biotechnology (DBT) has been proactive in establishing new institutions, fostering collaborative research endeavors, and nurturing strategic partnerships, both domestically and internationally, underscoring a holistic approach towards sectoral development.
Noteworthy achievements under the BioE3 Policy include the inauguration of India’s pioneering Biomanufacturing Institute in Mohali, the rollout of Bio-Artificial Intelligence hubs, biomanufacturing hubs, and biofoundries nationwide, and the establishment of specialized research cells focusing on cutting-edge areas like cell and gene therapy, climate-resilient agriculture, carbon sequestration, and functional foods. These initiatives underscore India’s commitment to driving innovation and pushing the boundaries of biotechnological applications.
A pivotal collaboration highlighted by the Minister is the memorandum of understanding between DBT and the Indian Space Research Organisation (ISRO) aimed at fostering synergy in space biotechnology and biomanufacturing. This partnership underscores the interdisciplinary nature of biotechnology and its potential to revolutionize diverse sectors through innovative applications and cross-sectoral collaborations.
In a groundbreaking development, three DBT-backed experiments were conducted on the International Space Station by Astronaut IAF Group Captain Shubhanshu Shukla earlier this year, showcasing India’s prowess in leveraging space biotechnology for scientific exploration and technological advancement. Such initiatives not only push the boundaries of innovation but also position India as a frontrunner in space biotechnology research.
At the state level, DBT has taken proactive steps to establish Centre-state partnerships, exemplified by the MoU with Assam to set up a BioE3 Cell and devise a strategic action plan tailored to the state’s unique needs. These decentralized collaborations underscore the importance of local engagement and customized solutions in driving biotechnological advancements at the grassroots level.
Globally, India’s diplomatic missions in 52 countries have actively engaged with stakeholders to share insights on the BioE3 policy framework, signaling India’s commitment to fostering international cooperation and knowledge exchange in the field of biotechnology. Collaborative efforts between DBT and the Ministry of External Affairs are poised to catalyze follow-up actions and strategic initiatives to further amplify India’s global footprint in biotechnological innovations.
- India’s bioeconomy poised for exponential growth, targeting $300 billion by 2030
- Strategic initiatives like BioE3 Challenge and National Biofoundry Network to drive sectoral development
- Collaborative efforts with ISRO underscore the interdisciplinary nature of biotechnology
- State-level partnerships and global engagements highlight a multi-faceted approach to biotechnological advancements
Tags: gene therapy, biomanufacturing
Read more on thehansindia.com